700+ Nurses, America’s Most Trusted Profession, Sign Statement Endorsing Biden-Harris

Diverse, bipartisan group of nurses from across the US band together to publish a public statement admonishing Trump
2-Oct-2020 12:40 PM EDT, by AmplifyThis!

October 2, 2020 

Newswise — The letter, drafted and signed by a self-described group of bipartisan nurse leaders, states, "We believe we have a moral obligation to speak out about the Trump administration's actions that are undermining the health of individuals, families, communities, the nation, and our planet."

The letter goes on to pledge that they will be voting for Joe Biden and Kamala Harris in November. Although the nurses do not represent a singular association or foundation, they are all willing to call out the Trump Administration's negligence and list the specific actions they feel are antithetical to the nursing values and code of ethics.

The letter asserts the opposite regarding candidate Joe Biden. The letter urges, "Joe Biden has demonstrated that he embraces evidence-informed policy, access to health care, safeguarding human rights, and other positions that align with nursing's values."

The endorsement concludes with, "We believe that he will restore a sense of humanity in our nation, strive to promote the health and well-being of all people and our planet using the best of science."

 

We Are Nurses, America's Most Trusted Profession. And We Support Biden-Harris

The Trump administration’s actions and policies are antithetical to a healthy society—and our code of ethics.  

For almost 20 years, the public has rated nurses as the most trusted profession in the nation. We are a diverse, bipartisan group of clinical, academic, research, policy and organizational nurse leaders who take that trust seriously. We have a moral obligation to speak out about the Trump administration’s actions that are undermining the health of individuals, families, communities, the nation and our planet. We urge the American people to carefully consider our concerns as they decide for whom to vote in the November elections. We will be voting for Joe Biden and Kamala Harris, but we are writing this as individuals, not on behalf of a campaign.

Here are a few examples of the Trump administration’s actions and policies that are antithetical to a healthy society and to nursing’s values and code of ethics:

These are but a few of our concerns about the Trump presidency. 

Joe Biden has demonstrated that he embraces evidence-informed policy, access to health care, safeguarding human rights and other positions that align with nursing’s values. While we may not all agree with his positions on all issues, we believe that he will restore a sense of humanity in our nation, strive to promote the health and well-being of all people and our planet using the best of science, and do so while once again rebuilding the nation’s economic viability, as he did with President Barack Obama after the 2008 recession. 

We urge Americans to vote for Joe Biden and Kamala Harris. The health and well-being of our nation is at stake.

On behalf of over 700 registered nurses from 49 states and the District of Columbia:

Jane Barnsteiner, Ph.D., R.N. FAAN, is a registered nurse living in Miramar Beach, Florida.

Joanne Disch, Ph.D., R.N., FAAN, is a registered nurse living in Miramar Beach, Florida.

Barbara Glickstein, MPH, M.S., R.N., is a public health nurse in New York City.

David Keepnews, Ph.D., J.D., R.N. FAAN, is a registered nurse, attorney and nursing professor in Washington, D.C. 

Katheren Koehn, M.A., R.N., FAAN, is the executive director of the Minnesota Organization of Registered Nurses, and lives in St Paul, Minnesota.

Mary Jo Kreitzer, Ph.D., R.N., FAAN, is a professor in Minneapolis. 

Diana J. Mason, Ph.D., R.N., FAAN, is a public health nurse, educator and consultant in Denver, New York.

Adriana Perez, Ph.D., ANP-BC, FAAN, is an educator and adult nurse practitioner in Philadelphia.

 

About AmplifyThis!

AmplifyThis! was founded late March to promote accurate and responsible messaging related to COVID-19 and health inequities. We partner with nationwide networks of experts and media outlets to support a public narrative that is rooted in science, equity and justice. Our objectives are to:

  • Amplify expert messaging with the goal of advancing beneficial and equitable health outcomes
  • Promote evidence-based messaging to counter misinformation and disinformation
  • Center the voices of women, Black people, people of color, and members of the LGBTQ community 
  • Focus attention on racial and gender healthcare disparities

For more information, contact AmplifyThis! at info@amplifythis.org.




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.47264